On Thursday 16th February 2023 Holiferm’s first commercial biosurfactant was opened by the Mayor of Wirral, Jeff Green. The opening ceremony was attended by representatives of biosurfactant and biochemical companies from around the world.

Holiferm hosted an opening ceremony for its first commercial biosurfactant plant on the afternoon of 16th February. The ceremony was very well attended by representatives of the biosurfactant community around the world, including those from Japan, Thailand, South Africa, Germany, France, Belgium and Australia. There was a very positive atmosphere within the room and the tours of the plant were very well received. It is hoped that this event will spring board Holiferm to commercial success and help the biosurfactant community to work together towards a common goal to remove the need for petrochemical based production methods.

The plant at Wallasey is a first of its kind facility. It will initially be producing circa 1100 tonnes of our biosurfactant using our patented fermentation with integrated gravity separation technology. The initial process will produce a range of sophorolipids for use in many applications including cosmetics, home care, personal care and I&I. This is the first of many such processes Holiferm hopes to design, test, patent and roll out to meet their mission to facilitate the manufacture of holistically sustainable bioproducts at a value point at which they are affordable to everyone therefore eliminating the need for petrochemicals.

Holiferm manufactures biosurfactants using a fermentation with integrated gravity separation technology. This method was designed and refined by our CEO Ben Dolman during his PhD studies at the University of Manchester. It underwent many design phases including a pilot plant trial stage to prove the efficacy of the system at a bespoke facility at SciTech Daresbury. As soon as this was proved plans to scale-up production were developed. A prime site at Ocean Park in Wallasey was quickly located. Once secured the design and build stage began.

Holiferm took control of the premises in January 2022 and set themselves an ambitious target to be running and manufacturing products within a year. This proved a challenging deadline for a number of reasons including the lengthening of delivery times and rising costs of materials. Throughout all the difficulties they faced they have kept moving forward. They adjusted to each challenge and pushed each other to find solutions to the issues they were presented with.

Holiferm are not content with sitting still though. They are already advanced in their research and development of processes for other molecules including rhamnolipids and MELs and hope to bring these to pilot plant scale in short order. Once successful they will then scale-up those methods again and incorporate them into their commercial plant to further penetrate the market.

For more information about Holiferm and their products please visit www.holiferm.com or contact info@holiferm.com.